After completing a BSc at Brown University, Providence, Rhode Island, Dr. Castellano gained his medical degree in 2005 at the University Clinic of Navarra in Spain. He subsequently completed a fellowship in Cardiology at the University of Navarra in 2010, where he obtained his PhD degree studying the role of Cardiotrophin-1 on cardiac structure and function in the context of the metabolic syndrome. Dr. Castellano completed a PostDoc degree on advanced clinical research under the direction of Dr. Fuster at Mount Sinai Cardiovascular Institute in New York. Currently, Dr. Castellano holds a position as adjunct Professor of Medicine at the Icahn School of Medicine at Mount Sinai Hospital. He is currently the coordinator of Clinical Trials at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid, Director of the Cardiovascular Health Program at Hospital Universitario Monteprincipe and Associate Professor of Medicine at CEU San Pablo. He is involved in numerous studies worldwide that study the various interventions in promotion of cardiovascular health and preventive cardiovascular medicine such as the SECURE trial (funded by H2020) and TANSNIP Study.